EUVIMEDEUVIMED entdecken
LeitlinieQualitative Studie

Attitudes toward the American Cancer Society’s 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians

Alexandra D Michel, Holly B Fontenot, Lindsay Fuzzell iD, Naomi C Brownstein iD, Paige Lake, Susan T Vadaparampil, Rebecca B Perkins iD

Cancer · 2024

DOI: 10.1002/cncr.35269 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Cancer, 2024. Verfasst von Alexandra D Michel und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, Rosalind Franklin University, North Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Attitude of Health Personnel, American Cancer Society. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 2020 American Cancer Society (ACS) guidelines are the most recent national guidelines for cervical cancer screening. These guidelines propose two major changes from current practice: initiating screening at age 25 years and using primary human papillomavirus (HPV) testing. Adoption of guidelines often occurs slowly, and therefore understanding clinician attitudes is important to facilitate practice change.

Methods

Interviews with a national sample of clinicians who perform cervical cancer screening in a variety of settings explored attitudes toward the two major changes from the 2020 ACS cervical cancer screening guidelines. Clinicians participated in 30‐ to 60‐min interviews exploring their attitudes toward various aspects of cervical cancer screening. Qualitative analysis was performed.

Results

Seventy clinicians participated from across the United States. Few respondents were initiating screening at age 25 years, and none were using primary HPV testing. However, over half would be willing to adopt these practices if supported by scientific evidence and recommended by professional medical organizations. Barriers to adoption included the lack of endorsement by professional societies, lack of laboratory availability and insurance coverage, limited autonomy within large health care systems, and concerns related to missed disease.

Conclusions

Few clinicians have adopted screening initiation or primary HPV testing, as recommended by the 2020 ACS guidelines, but over half were open to adopting these changes. Implementation may be facilitated via professional organization endorsement, clinician education, and laboratory, health care system, and insurance support. Plain Language Summary In 2020, the American Cancer Society (ACS) released updated guidelines for cervical cancer screening. The main changes to current practices were to initiate screening at age 25 years instead of age 21 years and to screen using primary human papillomavirus (HPV) testing rather than cytology alone or in combination with HPV testing. We performed in‐depth interviews with 70 obstetrics and gynecology, family medicine, and internal medicine physicians and advanced practice providers about their attitudes toward these guidelines. Few clinicians are following the 2020 ACS guidelines, but over half were open to changing practice if the changes were supported by evidence and recommended by professional medical organizations. Barriers to adoption included the lack of endorsement by professional medical organizations, logistical issues, and concerns about missed disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsEarly Detection of CancerAttitude of Health PersonnelAmerican Cancer SocietyPractice Guidelines as TopicPapillomavirus InfectionsQualitative ResearchHumansFemaleUnited StatesAdultMiddle AgedPractice Patterns, Physicians'Mass ScreeningMale

Stichwörter der Autor:innen

cancer preventioncervical cancer screeningclinical practice guidelineshuman papillomavirus (HPV)primary HPV testing

Autor:innen und Institutionen

  • College of Nursing, Rosalind Franklin University, North Chicago, Illinois, USA.
  • School of Nursing, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
  • Health Outcomes and Behavior, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
  • Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Chobanian & Avedisian School of Medicine, Boston University, Boston, Massachusetts, USA.

ORCID-Profile: Lindsay Fuzzell, Naomi C Brownstein, Rebecca B Perkins

Förderung

  • American Cancer Society

Zitieren

APA

Michel, A. D., Fontenot, H. B., Fuzzell, L., Brownstein, N. C., Lake, P., Vadaparampil, S. T., & Perkins, R. B. (2024). Attitudes toward the American Cancer Society’s 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians. Cancer. https://doi.org/10.1002/cncr.35269

Vancouver

Michel AD, Fontenot HB, Fuzzell L, Brownstein NC, Lake P, Vadaparampil ST, et al. Attitudes toward the American Cancer Society’s 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians. Cancer. 2024. doi:10.1002/cncr.35269

BibTeX
@article{Michel2024,
  author = {Michel, Alexandra D and Fontenot, Holly B and Fuzzell, Lindsay and Brownstein, Naomi C and Lake, Paige and Vadaparampil, Susan T and Perkins, Rebecca B},
  title = {Attitudes toward the American Cancer Society’s 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35269}
}
Kostenlos starten →